Treatment of mucopolysaccharidosis type II (Hunter syndrome) with idursulfase: the relevance of clinical trial end points

Author: Glamuzina Emma   Fettes Emma   Bainbridge Katie   Crook Victoria   Finnegan Niamh   Abulhoul Lara   Vellodi Ashok  

Publisher: Springer Publishing Company

ISSN: 0141-8955

Source: Journal of Inherited Metabolic Disease, Vol.34, Iss.3, 2011-06, pp. : 749-754

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content